(Q42243408)

English

Decrease of serum pyridoxal phosphate levels and homocystinemia after administration of 6-azauridine triacetate and their prevention by administration of pyridoxine

scientific article published on December 15, 1982

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Decrease of serum pyridoxal phosphate levels and homocystinemia after administration of 6-azauridine triacetate and their prevention by administration of pyridoxine (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

1 reference

10.1016/0006-2952(82)90664-5

https://api.crossref.org/works/10.1016/0006-2952(82)90664-5

23 August 2023

1 reference

10.1016/0006-2952(82)90664-5

https://api.crossref.org/works/10.1016/0006-2952(82)90664-5

23 August 2023

author name string

M. Slavik

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6186258

23 August 2023

K. J. Smith

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6186258

23 August 2023

O. Blanc

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6186258

23 August 2023

language of work or name

0 references

publication date

1 December 1982

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

15 December 1982

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6186258

23 August 2023

full work available at URL

https://api.elsevier.com/content/article/PII:0006295282906645?httpAccept=text/xml

1 reference

10.1016/0006-2952(82)90664-5

https://api.crossref.org/works/10.1016/0006-2952(82)90664-5

23 August 2023

https://api.elsevier.com/content/article/PII:0006295282906645?httpAccept=text/plain

1 reference

10.1016/0006-2952(82)90664-5

https://api.crossref.org/works/10.1016/0006-2952(82)90664-5

23 August 2023

Biochemical Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

31

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

24

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

4089-4092

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Typical hyperaminoaciduria after high doses of 6-azauridine triacetate

3

1 reference

10.1016/0006-2952(82)90664-5

https://api.crossref.org/works/10.1016/0006-2952(82)90664-5

23 August 2023

‘Homocystinuria’ and urinary excretion of β-amino acids in patients treated with 6-azauridine

4

1 reference

10.1016/0006-2952(82)90664-5

https://api.crossref.org/works/10.1016/0006-2952(82)90664-5

23 August 2023

Changes in serum and urine amino acids in patients with progressive systemic sclerosis treated with 6-azauridine triacetate

7

1 reference

10.1016/0006-2952(82)90664-5

https://api.crossref.org/works/10.1016/0006-2952(82)90664-5

23 August 2023

Cancer Treatment Reports

8

63

1041

author name string

Slavik

publication date

1979

1 reference

10.1016/0006-2952(82)90664-5

https://api.crossref.org/works/10.1016/0006-2952(82)90664-5

23 August 2023

Effect of 6-azauracil, and of certain structurally similar compounds, on three pyridoxal-phosphate requiring enzymes involved in neurotransmitter metabolism

9

1 reference

10.1016/0006-2952(82)90664-5

https://api.crossref.org/works/10.1016/0006-2952(82)90664-5

23 August 2023

A simple enzymic assay for pyridoxal phosphate

11

1 reference

10.1016/0006-2952(82)90664-5

https://api.crossref.org/works/10.1016/0006-2952(82)90664-5

23 August 2023

Beneficial Effects of Triacetyl Azauridine in Psoriasis and Mycosis Fungoides

16

1 reference

10.1016/0006-2952(82)90664-5

https://api.crossref.org/works/10.1016/0006-2952(82)90664-5

23 August 2023

Treatment of mycosis fungoides with 6-azauracilriboside

17

1 reference

10.1016/0006-2952(82)90664-5

https://api.crossref.org/works/10.1016/0006-2952(82)90664-5

23 August 2023

Calabresi P: Treatment of polycythemia vera with azauridine and azaribine

19

1 reference

10.1016/0006-2952(82)90664-5

https://api.crossref.org/works/10.1016/0006-2952(82)90664-5

23 August 2023

6-azauridine-induced changes of the trophoblast in early human pregnancy

20

1 reference

10.1016/0006-2952(82)90664-5

https://api.crossref.org/works/10.1016/0006-2952(82)90664-5

23 August 2023

Letter: Thrombosis and psoriasis

22

1 reference

10.1016/0006-2952(82)90664-5

https://api.crossref.org/works/10.1016/0006-2952(82)90664-5

23 August 2023

Nucleoside analogs in the treatment of nonneoplastic diseases

25

1 reference

10.1016/0006-2952(82)90664-5

https://api.crossref.org/works/10.1016/0006-2952(82)90664-5

23 August 2023

Identifiers

10.1016/0006-2952(82)90664-5

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42243408&oldid=1959686089"